MYASTHENIA GRAVIS

This adverse event was reported 8085 times

These drugs are most commonly taken by patients reporting MYASTHENIA GRAVIS:

# Drug Count
0 PREDNISONE 940
1 PYRIDOSTIGMINE BROMIDE 878
2 EFGARTIGIMOD ALFA 785
3 ECULIZUMAB 574
4 PEMBROLIZUMAB 549
5 RAVULIZUMAB 511
6 ACETAMINOPHEN 486
7 NIVOLUMAB 485
8 PYRIDOSTIGMINE BROMIDE ORAL 437
9 GABAPENTIN 393
See all common drugs associated with MYASTHENIA GRAVIS

MYASTHENIA GRAVIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMMONIUM CHLORIDE 106 0.4240
1 EFGARTIGIMOD ALFA 785 0.1978
2 CHLORAMPHENICOL SODIUM SUCCINATE 5 0.1515
3 ASIAN GINSENG 60 0.1422
4 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 68 0.1402
5 NATAMYCIN 55 0.1341
6 BISMUTH SUBGALLATE 6 0.1304
7 PYRIDOSTIGMINE BROMIDE ORAL 437 0.1230
8 PYRIDOSTIGMINE BROMIDE 878 0.1151
9 SODIUM CITRATE 135 0.1075
See all drugs enriched for association with MYASTHENIA GRAVIS

MYASTHENIA GRAVIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Neonatal Fc Receptor Blocker [EPC] 1191 0.2715
1 Polyene Antimicrobial [EPC] 55 0.1341
2 Interleukin-5 Antagonist [EPC] 50 0.0727
3 Endoglycosidase [EPC] 70 0.0378
4 Osmotic Diuretic [EPC] 140 0.0268
5 Lymphocyte Activation Gene-3 Blocker [EPC] 12 0.0233
6 Vitamin K [EPC] 192 0.0222
7 Complement Inhibitor [EPC] 1016 0.0181
8 Bismuth [EPC] 76 0.0136
9 Human Immunoglobulin G [EPC] 275 0.0131
See all drug classes enriched for association with MYASTHENIA GRAVIS